You searched for Humanized antibody - Page 40 of 45

News and Trends 27 Nov 2018

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Adrenomed closed a €24M Series D round to fund further development of its antibody drug that treats septic shock by preventing excessive fluid loss and preserving the blood vessel walls….

November 27, 2018 - 3 minutesmins - By Helen Albert

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

…Gilead Sciences’ remdesivir. In November and December, several antibody drugs were greenlit, including regdanvimab developed by the South Korean company Celltrion and sotrovimab, marketed by GSK. However, the rise of…

February 15, 2022 - 7 minutesmins - By Jonathan Smith

In Depth 5 Nov 2024

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

…as ANB033 (anti-CD122 antagonist antibody) entering a phase 1 trial, and ANB101 (BDCA2 modulator antibody) in preclinical development. Moreover, just after it announced it wanted to separate its consumer health…

November 5, 2024 - 9 minutesmins - By Jules Adam

mereo biopharma brittle bone disease osteogenesis imperfecta

More News! 11 Nov 2019

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

…bone disease. Mereo tested different doses of its antibody drug in 112 adults with osteogenesis imperfecta in a 12-month phase IIb trial. The drug failed to meet the main endpoint…

November 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2023

Disc Medicine raises $62.5M for hematology programs

…DISC-0974 (hepcidin suppression) is another treatment in the pipeline. It is a first-in-class, investigational, anti-hemojuvelin (HJV) monoclonal antibody designed to suppress hepcidin production and increase serum iron to enable erythropoiesis….

February 14, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 2 Apr 2024

Chicago biotech: Seven players advancing the industry

…is a biopharmaceutical company focused on developing therapies that target senescent cells and cancer. Their leading compound, SIWA318H, is an antibody that targets advanced glycation end products (AGEs), which are…

April 2, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…Among them is a vaccine for malaria, which has received significant attention and funding, including $12.2 million from the EU Malaria Fund. Another prominent candidate is MAbCo19, a monoclonal antibody…

August 22, 2024 - 9 minutesmins - By Jules Adam

News and Trends 13 Dec 2017

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Regeneron and Sanofi have announced positive early results from a Phase II study investigating their skin cancer antibody, cemiplimab. Despite deciding to end their antibody partnership at the end of…

December 13, 2017 - 3 minutesmins - By Alex Dale

Interview 27 Mar 2017

Meet one of the Most Successful Biotech Entrepreneurs in the UK

…Molecular Genetics at Leicester, and then a postdoc at Bath on antibody engineering, before moving to Cambridge to work at the GURDON Institute. It was during his postdoc and his…

March 27, 2017 - 7 minutesmins - By Philip Hemme

News and Trends 21 Feb 2023

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

…Maraganore, chair of Hemab’s board of directors. About HMB-001 HMB-001 is bispecific antibody that binds and stabilizes endogenous factor VIIa (FVIIa) with one antibody arm and TLT-1 on activated platelets…

February 21, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 27 Apr 2016

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase IIb/III trial for a muscle disease (sIBM), conducted by Novartis. Sad news for Novartis and…

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

…commercial milestone payments up to $637 million plus mid-single to low double-digit royalties on sales. About Affibody molecules Affibody molecules are a novel class of antibody mimetics with characteristics surpassing…

March 8, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

Disc Medicine raises $62.5M for hematology programs

Chicago biotech: Seven players advancing the industry

Seven companies transforming the biotech industry in Italy

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Meet one of the Most Successful Biotech Entrepreneurs in the UK

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

Affibody and Chiesi Group to develop treatments for respiratory diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!